Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shubin, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shubin, H.
(Chest. 1965;48:287-290.)
© 1965 American College of Chest Physicians

Long Term (Five or More Years) Administration of Corticosteroids in Pulmonary Diseases

Harry Shubin M.D., F.C.C.P.1

1 Broad Street Hospital and Medical Center, Wolffe Hospital, Philadelphia General Hospital and Germantown Hospital

Long term, maintenance or supportive (2 to 12 mg. daily) treatment with corticosteroids is often necessary to maintain symptomatic improvement. In this study, we found the same clinical action whether the corticoid was given once daily, or in divided doses. This tends to confirm the recent report of Demos, et al.9 on once daily therapy.

The beneficial effects can be complicated by undesirable side reactions. For supportive and prophylactic care, all patients were on high protein diets (re: osteoporosis); in between feedings, milk, etc. (re: ulcer); adequate water intake (avoiding a concentrated urine with hypercalciuria); isoniazid 100 mg. three times a day (against reactivating tuberculosis) with regular complete examinations, including laboratory evaluation. The concurrent administration of anabolic steroids (androgen and estrogen) has been shown to control osteoporosis. Unfortunately, the moon faces often appear early in the course of treatment and persist in a large group of patients.

Finally, the corticosteroids are potent, effective drugs for acute and chronic pulmonary diseases. They should be used with discretion, when indicated, under close clinical supervision.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by the American College of Chest Physicians.